{{see also|Beta blocker}}

 


 
Atenolol was the main β-blocker identified as carrying a higher risk of provoking [[Diabetes mellitus type 2|type 2 diabetes]], leading to its downgrading in the United Kingdom in June 2006 to fourth-line agent in the management of hypertension.<ref name="NHSnews">{{cite web|author=Sheetal Ladva |title=NICE and BHS launch updated hypertension guideline |url=http://www.nelm.nhs.uk/Record%20Viewing/viewRecord.aspx?id= |date=2006-06-28 |publisher=[[National Institute for Health and Clinical Excellence]] |accessdate= |deadurl=yes |archiveurl=https://web.archive.org/web/20080617025556/http://www.nelm.nhs.uk/Record%20Viewing/viewRecord.aspx?id= |archivedate=17 June 2008 |df=dmy }}</ref>

 


 
Antihypertensive therapy with atenolol provides weaker protective action against cardiovascular complications (e.g. myocardial infraction and [[stroke]]) compared to other antihypertensive drugs. In some cases, [[diuretic]]s are superior.<ref name="pmid15530629">{{cite journal |vauthors=Carlberg B, Samuelsson O, Lindholm LH |title=Atenolol in hypertension: is it a wise choice? |journal=The Lancet |volume=364 |issue=9446 |pages=1684–9 |year=2004 |pmid=15530629 |doi=10.1016/S0140-6736(04)17355-8}}</ref> In addition, atenolol has been found to lack mortality benefits<ref>{{cite journal | pmc = 3941231 | pmid=24672712 | doi=10.1155/2014/919256 | volume=2014 | title=Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease | year=2014 | journal=International Journal of Hypertension | pages=919256 | vauthors=Tomiyama H, Yamashina A}}</ref><ref>{{cite journal | pmc = 4371808 | pmid=25821584 | doi=10.1136/openhrt-2014-000230 | volume=2 | title=&beta;-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature | year=2015 | journal=Open Heart | pages=e000230 | vauthors=DiNicolantonio JJ, Fares H, Niazi AK, Chatterjee S, D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Lavie CJ, Bell DS, O'Keefe JH}}</ref> and even to increase mortality in older adults.<ref name="ncbi.nlm.nih.gov"/>

 

